XBiotech Inc. (NASDAQ:XBIT – Get Free Report)’s share price crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $6.63 and traded as high as $7.93. XBiotech shares last traded at $6.79, with a volume of 289,689 shares trading hands.
XBiotech Stock Down 14.6 %
The company has a market cap of $206.82 million, a PE ratio of -6.66 and a beta of 1.41. The stock’s 50 day moving average is $6.63 and its 200-day moving average is $7.10.
XBiotech (NASDAQ:XBIT – Get Free Report) last announced its earnings results on Monday, August 12th. The biopharmaceutical company reported ($0.43) earnings per share for the quarter.
Institutional Inflows and Outflows
About XBiotech
XBiotech Inc, a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation.
Featured Stories
- Five stocks we like better than XBiotech
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Investing in Construction Stocks
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for XBiotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XBiotech and related companies with MarketBeat.com's FREE daily email newsletter.